Adjuvant chemotherapy after radical cystectomy: Do all patients who need chemotherapy after surgery actually receive it?
Abstract. Background. Compliance with the guideline recommendations for neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer is incomplete. The adjuvant chemotherapy approach has the advantage of pathology-based decision-making, allowing for patient selection. In addition, radica...
Main Authors: | Roy Croock, Jonathan Modai, Yuval Avda, Igal Shpunt, Morad Jaber, Yamit Peretz, Yaniv Shilo, Dan Leibovici |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health
2023-06-01
|
Series: | Current Urology |
Online Access: | http://journals.lww.com/10.1097/CU9.0000000000000099 |
Similar Items
-
Potential Markers to Reduce Non-Contrast Computed Tomography Use for Symptomatic Patients with Suspected Ureterolithiasis
by: Yuval Avda, et al.
Published: (2022-08-01) -
Does adjuvant chemotherapy improve survival after radical cystectomy for urothelial bladder carcinoma with malignant lymph node involvement?
by: M. Laymon, et al.
Published: (2020-07-01) -
Fascial dehiscence after radical cystectomy: Is abdominal exploration mandatory?
by: Paz Lotan, et al.
Published: (2022-09-01) -
Nutritional Status Impairment Due to Neoadjuvant Chemotherapy Predicts Post-Radical Cystectomy Complications
by: Sharon Cohen, et al.
Published: (2021-12-01) -
Adjuvant chemotherapy is ineffective in patients with bladder cancer and variant histology treated with radical cystectomy
by: S. Zamboni, et al.
Published: (2020-07-01)